factor

(redirected from platelet-derived growth factor)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.

Factor

A financial institution that buys a firm's accounts receivable and collects the accounts.
Copyright © 2012, Campbell R. Harvey. All Rights Reserved.

Factor

A third party that buys a firm's accounts receivable. If a firm is not confident in its ability to collect on its credit sales, it may sell the right to receive payment to the factor at a discount. The factor then assumes the credit risk associated with the accounts receivable. This provides the firm immediate access to working capital, which is important, especially if the firm has a cash flow problem. The price of factoring is determined by the creditworthiness of the firm's customer, not of the firm itself. It is also known as accounts receivable financing.
Farlex Financial Dictionary. © 2012 Farlex, Inc. All Rights Reserved

factor

A firm that purchases accounts receivable from another firm at a discount. The purchasing firm then attempts to collect the receivables.

factor

To sell accounts receivable to another party at a discount from face value. Thus, a firm in need of cash to pay down short-term debt may decide to factor its accounts receivable to another firm.
Wall Street Words: An A to Z Guide to Investment Terms for Today's Investor by David L. Scott. Copyright © 2003 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved. All rights reserved.

factor

  1. a firm that purchases TRADE DEBTS from client firms. See FACTORING.
  2. a firm that buys in bulk and performs a WHOLESALING function.
  3. an input (for example raw material, labour, capital) which is used to produce a good or provide a service.
Collins Dictionary of Business, 3rd ed. © 2002, 2005 C Pass, B Lowes, A Pendleton, L Chadwick, D O’Reilly and M Afferson

factor

  1. 1a FACTOR INPUT that is used in production (see NATURAL RESOURCES, LABOUR, CAPITAL).
  2. a business that buys in bulk and performs a WHOLESALING function.
  3. a business that buys trade debts from client firms (at some agreed price below the nominal value of the debts) and then arranges to recover them for itself. See FACTOR MARKET, FACTORING.
Collins Dictionary of Economics, 4th ed. © C. Pass, B. Lowes, L. Davies 2005
References in periodicals archive ?
Sumida et al., "Expression of platelet-derived growth factor (PDGF)-B and PDGF-receptor [beta] is associated with lymphatic metastasis in human gastric carcinoma," Cancer Science, vol.
Thomason, "Platelet-derived growth factor (BB homodimer), transforming growth factor-[beta]1, and basic fibroblast growth factor in dermal wound healing: neovessel and matrix formation and cessation of repair," The American Journal of Pathology, vol.
MacDonald et al., "Platelet-derived growth factor induces a long-term inhibition of N-methyl-D-aspartate receptor function," Journal of Biological Chemistry, vol.
Macrophages also secrete platelet-derived growth factor and vascular endothelial growth factor which initiate the formation of granulation tissue and thus initiate the transition into the proliferative phase and tissue regeneration [6].
Seppa et al., "Platelet-derived growth factor is chemotactic for fibroblasts," Journal of Cell Biology, vol.
Sunitinib.--Sunitinib is a tyrosine kinase inhibitor that blocks the VEGF receptor, as well as platelet-derived growth factor receptor, FLT-3, and c-KIT.
Sorafenib inhibits KIT, the vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR), and BRAF kinases.
BioMimetic believes the condition can be treated with a recombinant human platelet-derived growth factor. The treatment is intended to be used along with a cartilage and bone graft.
It was thought that relatively high concentrations of vascular endothelial growth factor, platelet-derived growth factor, and transforming growth factor--beta could help regenerate tendon tissue "through increased tendon cell proliferation, collagen synthesis, and vascularization."
Imatinib is a tyrosine kinase receptor antagonist that inhibits the mutated tyrosine kinases such as Bcr-Abl, c-kit, and platelet-derived growth factor receptor (PDGFR) in some malignancies.
It is activated by various growth factors and cytokines, including platelet-derived growth factor, VEGF and IL-6.

Full browser ?